Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent.

Slides:



Advertisements
Similar presentations
The perspective of a person with hepatitis C on new treatments and treatment as prevention Jack Wallace, Research Fellow. Australian Research Centre in.
Advertisements

Management of Chronic HCV Infection by PMDs Rod Rahimi Osler Journal Club
HEPATITIS C VIRUS REINFECTION IN PEOPLE WHO INJECT DRUG (PWID) PREVIOUSLY SUCCESFULY TREATED G. Ntetskas, V. Papastergiou, L. Skorda, A. Katsili, E. Anastasiou,
Pennsylvania: The State of HCV 2015
OVERVIEW OF PROJECT INSPIRE NYC Marie Bresnahan, MPH Project Director May 20,
Bringing Hepatitis C Treatment into the Medical Home A Pilot Program for Drug Users Dr. Joanna Eveland MS, MD, Clinical Chief for Special Populations Mission.
Services and C Leon Wylie Lead Officer Hepatitis Scotland.
HCV Elimination Is it possible?.
Where Are We on the Path to Elimination of Chronic Hepatitis C?
An Overview for Healthcare Providers
Addressing Viral Hepatitis
Charlie Howsare, MD MPH Pa. Viral Hepatitis Prevention Coordinator
The changing landscape of hepatitis infection
An Overview for Healthcare Providers
Addressing the Intersection of Substance Abuse and Viral Hepatitis
Interactive Workshop.
Hepatitis C Allies of Philadelphia August 2, 2017
Current harm reduction program at outreach
FUTURE RECOMMENDATIONS
Cherokee Nation Health Services HCV Elimination Program
Lesson 3: The HCV Care Continuum
Documenting barriers to access HCV care and treatment: a peer-led research João Santa Maria, Magda Ferreira, Renato Pinto, Joana Sanches, Álvaro Ávila,
Community Mental Health Authority of Clinton, Eaton, Ingham Counties
Core Competency 4: HCV Treatment
Building a Data Driven HCV Screening and Linkage-to-Care Program
Talking to Patients About HCV Treatment
Testing and linking different key population groups in Ukraine
MEDICATION THERAPY MANAGEMENT SERVICES
Chronic Hepatitis C Virus Infection
One pill a day, can keep HIV away
Starting Strong: Initial Evaluation of the Patient With HCV
HCV: Who Should We Screen and Why?
Hyperkalemia in the Hospital: Collaboration to Improve Transitions of Care.
Expanding the Universe of Viral Hepatitis Treaters
Program Goals Overview of HIV Epidemic HIV and Communities of Color.
World Epidemiology. Are HIV and Other Chronic Diseases Models Applicable to Viral Hepatitis? Focus on HCV.
HCV Care in Unique Patient Populations
The HCV Revolution: Are You and Your Practice Ready?
Optimizing HIV Care By Guiding and Educating the Workforce
Patient-Centered Care in Cystic Fibrosis
Best Practices in Screening and Linkage to Care in Hepatitis C Virus
Before and After: Patient Cases in Onychomycosis
Ending HCV: How Do We Get There From Here?
More Than Treatment.
HCV Screening.
HBV Infection: Some Sobering Facts
HBV Care Models: Community Collaborations for Best Practices
What Does the Primary Care Physician Need to Know About Chronic Hepatitis C?
Engaging and Educating the Multidisciplinary Healthcare Team in HCV Care.
Talking to Patients About Diabetes Management
Managing Depression is a Team Effort:
From Start to Finish: Initial and Ongoing Care for Men Receiving PrEP
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Overcoming Clinical Inertia
Reporting.
Providing community health workers for north Tulsa communities
School Consortium Challenge:
Hepatitis C: After the Diagnosis
Treat first! Shade says…
Managing Age-Related Clinical Issues in Hemophilia
A Guideline-Based Approach to HCV Care
Hepatitis C Virus Diagnosis and the Holy Grail
Improving Adherence to Antiplatelet Therapy After an ACS Event
REAL-WORLD SAFETY, EFFECTIVENESS, AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION TREATED WITH GLECAPREVIR/PIBRENTASVIR:
Strategies for Infection Control in Cystic Fibrosis
Removing Barriers in the HCV Cascade of Care
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Lesson 3: Treatment as Prevention
Lesson 3: The HCV Care Continuum
Managing Hepatitis C in Vermont
Presentation transcript:

Community Advocacy for HCV: Identify, Link to Care, and Treat to Prevent

HCV in Austin, Texas The Early Days

Austin Hepatitis Clinic Opened in 1998

Epidemiology and Demographics of HCV Infection in the Austin Community Fastest Rise in Number of New HCV Cases in Young PWID

Treatment of HCV Infection From No Hope to Cure in Less Than 30 Years

Benefits of Curing Chronic HCV Infection

The Face of HCV Infection

Low-Threshold HCV Care Knocking Down the Barriers Is the Key to Success

Acute HCV Among Persons Aged ≤ 30 Years Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012

Recommendations for the Identification of Chronic HCV Infection in Persons Born During 1945-1965

Identify  Screen  Link to Care  Treat to Prevent

Tele-Education: The Future of Curing Chronic HCV Infection Project ECHO Texas: Baylor St. Luke's Medical Center

Advocating for the Patient: Early Access to the First Interferon-Free Therapy

Patient Navigator for HCV Screening and Linkage to Care Walking the Talk

The Treatment Cascade for Chronic HCV Infection in the United States

Patient Navigator Bridging the Gap Between Screening and Linkage to Care

Adherence to Treatment Is Critical

Preventing Reinfection Care Doesn’t Stop With the Cure

Expanding the HCV Treater Pool Bringing Value to the Community

Abbreviations